Gentronix Reformats GreenScreen HC for Higher Throughput | GenomeWeb

Scientists at Manchester, UK-based genotoxicity screening shop Gentronix this week said they have developed and validated a higher-throughput version of the company’s GreenScreen HC genotoxicity assay.

The new GADD45a-GFP human cell-based assay was reformatted from four compounds per 96-well microplate to test 12 compounds per plate from a starting concentration of 100 µM over three serial dilutions in a higher-throughput, automated screening mode, a company official told CBA News this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.